Skip Navigation LinksHome > February 2008 - Volume 30 - Issue 1 > CD117 Immunoreactivity in Atypical Fibroxanthoma
American Journal of Dermatopathology:
doi: 10.1097/DAD.0b013e31815b8ed5
Original Article

CD117 Immunoreactivity in Atypical Fibroxanthoma

Mathew, Rahel A MD*; Schlauder, Scott M MD†; Calder, Kenneth B MD*; Morgan, Michael B MD*†

Collapse Box

Abstract

Atypical fibroxanthoma (AFX) is a spindle cell neoplasm of the skin seen typically on sun-damaged skin of the elderly. Though described as a benign entity, local recurrence and distant metastasis have been reported. This study aims to investigate the potential pathogenic role of CD117, the c-kit receptor in AFX. CD117 was detected in 15 of the 16 cases (94%). The percentage of positive cells for CD117 expression among all tumors was approximately 30%. CD117 proved to be a very sensitive marker of AFX. This antibody may be a useful diagnostic adjunct in AFX.

© 2008 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.